Form 4: Bio-Rad Laboratories Executive Acquires Stock Options
SEC Form 4 Filing
Michael Crowley, EVP at Bio-Rad Laboratories, reports acquisition of stock options.
Summary
- Michael Crowley, an EVP at Bio-Rad Laboratories, acquired 3,535 non-qualified stock options on March 8, 2024.
- The exercise price of these options is $343.76.
- The options vest over four years, with 25% vesting each year on the anniversary of the grant date.
- The expiration date for these options is March 8, 2034.
- Following the transaction, Crowley directly owns 3,535 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of stock option grants.
Industry Context
This filing is a routine disclosure of stock option grants to company executives, which is a common practice in publicly traded companies to incentivize and retain key personnel.
Stakeholder Impact
- The stock option grant could potentially incentivize the executive to improve company performance, which would benefit shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/08/2024 | Date of stock option transaction |
| 03/08/2034 | Expiration date of the stock options |
| 03/11/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.